Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.

CCR4, C-X-C chemokine receptor type 4 CHOPE, cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide CMR, cardiac magnetic resonance ECG, electrocardiogram ICI, checkpoint inhibitor LGE, late gadolinium enhancement LVEF, left ventricular ejection fraction MR sequences PE, pulmonary embolus TTE, transthoracic echocardiogram Treg, T regulatory cells acute heart failure cancer cardiomyopathy

Journal

JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292

Informations de publication

Date de publication:
07 Jul 2021
Historique:
received: 04 01 2021
revised: 26 03 2021
accepted: 02 04 2021
entrez: 28 7 2021
pubmed: 29 7 2021
medline: 29 7 2021
Statut: epublish

Résumé

A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge with the therapy. (

Identifiants

pubmed: 34317676
doi: 10.1016/j.jaccas.2021.04.001
pii: S2666-0849(21)00320-X
pmc: PMC8311348
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1018-1023

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

This work was supported by American Heart Association (grant #18CDA34110361; LAB, 2018). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Références

J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764
pubmed: 29567210
Heart. 2009 May;95(9):759-60
pubmed: 19221107
Onco Targets Ther. 2019 Feb 07;12:1085-1094
pubmed: 30799938
Front Pharmacol. 2019 Nov 29;10:1350
pubmed: 31849640
Oncologist. 2018 Aug;23(8):879-886
pubmed: 29802219
N Engl J Med. 2019 Jun 13;380(24):2375-2376
pubmed: 31189042
J Clin Invest. 2017 Mar 1;127(3):801-813
pubmed: 28134623
Circulation. 2019 Jul 02;140(2):80-91
pubmed: 31390169
Eur J Heart Fail. 2020 Nov;22(11):1945-1960
pubmed: 32463967
ARYA Atheroscler. 2018 Jul;14(4):183-187
pubmed: 30627195
J Clin Oncol. 2018 Jun 10;36(17):1714-1768
pubmed: 29442540
Immunity. 2015 Jun 16;42(6):1087-99
pubmed: 26070483
Cancer Res. 2016 Sep 1;76(17):5068-79
pubmed: 27402079

Auteurs

Jennifer M Kwan (JM)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Natalija Odanovic (N)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Amit Arbune (A)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Angela Higgins (A)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Mariana Henry (M)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Daniel Greif (D)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Francine Foss (F)

Section of Hematology, Yale University School of Medicine, New Haven, Connecticut, USA.

Lauren A Baldassarre (LA)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Classifications MeSH